Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral Neuropathy

Diabetic peripheral neuropathy (DPN) remains one of the most common and serious complications of diabetes. Currently, pharmacological agents are limited to treating the pain associated with DPN, and do not address the underlying pathological mechanisms driving nerve damage, thus leaving a significan...

Descripción completa

Detalles Bibliográficos
Autores principales: Cox, April Ann, Sagot, Yves, Hedou, Gael, Grek, Christina, Wilkes, Travis, Vinik, Aaron I., Ghatnekar, Gautam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411416/
https://www.ncbi.nlm.nih.gov/pubmed/28512447
http://dx.doi.org/10.3389/fendo.2017.00089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411416/
https://www.ncbi.nlm.nih.gov/pubmed/28512447
http://dx.doi.org/10.3389/fendo.2017.00089

Ejemplares similares